ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Foghorn Therapeutics
Foghorn Therapeutics is seeking a Director, DMPK project representative to support multiple project teams in the discovery and early clinical development of novel therapies targeting the chromatin regulatory system. The role involves designing ADME/PK studies, analyzing data, collaborating across disciplines, and contributing to decision-making and regulatory documentation.
Headquarters
Watertown, Massachusetts, United States
Company Size
51-200 employees
Founded
2016
Foghorn Therapeutics is a biotechnology company focused on the chromatin regulatory system, aiming to treat cancer and other diseases by modulating gene regulation. Its Gene Traffic Control™ platform is designed to identify and drug chromatin regulators that control gene expression. By targeting the chromatin regulatory network, Foghorn seeks to develop precision therapies with novel mechanisms of action. The company positions itself at the intersection of epigenetics and oncology, translating chromatin biology into new medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Foghorn Therapeutics.
60% above the average for this role
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
2 weeks ago
